BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9466145)

  • 1. Contingent valuation with an open-ended follow-up question: a test of scope effects.
    Kartman B; Stålhammar NO; Johannesson M
    Health Econ; 1997; 6(6):637-9. PubMed ID: 9466145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valuation of health changes with the contingent valuation method: a test of scope and question order effects.
    Kartman B; Stålhammar NO; Johannesson M
    Health Econ; 1996; 5(6):531-41. PubMed ID: 9003940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aiding priority setting in health care: is there a role for the contingent valuation method?
    Olsen JA
    Health Econ; 1997; 6(6):603-12. PubMed ID: 9466142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations?
    Søgaard R; Lindholt J; Gyrd-Hansen D
    Appl Health Econ Health Policy; 2012 Nov; 10(6):397-405. PubMed ID: 22963163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of the contingent valuation market in health care: a critical assessment.
    Smith RD
    Health Econ; 2003 Aug; 12(8):609-28. PubMed ID: 12898660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical implications of response acquiescence in discrete-choice contingent valuation.
    Yeung RY; Smith RD; Ho LM; Johnston JM; Leung GM
    Health Econ; 2006 Oct; 15(10):1077-89. PubMed ID: 16518835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for antihypertensive therapy--results of a Swedish pilot study.
    Johannesson M; Jönsson B; Borgquist L
    J Health Econ; 1991; 10(4):461-73. PubMed ID: 10117014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingent valuation: (still) on the road to nowhere?
    Smith RD; Sach TH
    Health Econ; 2009 Aug; 18(8):863-6. PubMed ID: 19565468
    [No Abstract]   [Full Text] [Related]  

  • 9. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay.
    Gyrd-Hansen D; Jensen ML; Kjaer T
    Health Econ; 2014 May; 23(5):550-63. PubMed ID: 23696155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening.
    Whynes DK; Frew E; Wolstenholme JL
    J Health Econ; 2003 Jul; 22(4):555-74. PubMed ID: 12842315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stated and actual altruistic willingness to pay for insecticide-treated nets in Nigeria: validity of open-ended and binary with follow-up questions.
    Onwujekwe O; Uzochukwu B
    Health Econ; 2004 May; 13(5):477-92. PubMed ID: 15127427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliciting willingness to pay: comparing closed-ended with open-ended and payment scale formats.
    Frew EJ; Whynes DK; Wolstenholme JL
    Med Decis Making; 2003; 23(2):150-9. PubMed ID: 12693877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay for arthritis symptom alleviation. Comparison of closed-ended questions with and without follow-up.
    Slothuus U; Larsen ML; Junker P
    Int J Technol Assess Health Care; 2000; 16(1):60-72. PubMed ID: 10815354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of risk-free cigarettes--do smokers underestimate the risk?
    Hammar H; Johansson-Stenman O
    Health Econ; 2004 Jan; 13(1):59-71. PubMed ID: 14724894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating Willingness to Pay for an Improved Service Delivery to Patients Referring Namazi Hospital Chemical Therapy Ward in Iran Using Contingent Valuation.
    Kavosi Z; Jafari A; Keshtkaran V; Pourahmadi E
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1817-1823. PubMed ID: 30049193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of protest zeros on estimates of willingness to pay in healthcare contingent valuation analysis.
    Fonta WM; Ichoku HE; Kabubo-Mariara J
    Appl Health Econ Health Policy; 2010; 8(4):225-37. PubMed ID: 20578778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Questions about the costs of therapy of reflux esophagitis].
    Topál L
    Orv Hetil; 1999 Mar; 140(11):625-7. PubMed ID: 10379172
    [No Abstract]   [Full Text] [Related]  

  • 18. Valuing the benefits of a health intervention using three different approaches to contingent valuation: re-treatment of mosquito bed-nets in Nigeria.
    Onwujekwe O; Fox-Rushby J; Hanson K
    J Health Serv Res Policy; 2004 Apr; 9(2):67-75. PubMed ID: 15099453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criterion and content validity of a novel structured haggling contingent valuation question format versus the bidding game and binary with follow-up format.
    Onwujekwe O
    Soc Sci Med; 2004 Feb; 58(3):525-37. PubMed ID: 14652049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh.
    Heinzen RR; Bridges JF
    Int J Technol Assess Health Care; 2008; 24(4):481-7. PubMed ID: 18828944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.